p45 NF-E2 Polyclonal Antibody, PE-Cy5.5 Conjugated
Applications
Reactivity
Predicted Reactivity
Overview | |
Catalog # | bs-22023R-PE-Cy5.5 |
Product Name | p45 NF-E2 Polyclonal Antibody, PE-Cy5.5 Conjugated |
Applications | WB |
Reactivity | Human |
Predicted Reactivity | Mouse, Rat, Rabbit |
Specifications | |
Conjugation | PE-Cy5.5 |
Host | Rabbit |
Source | KLH conjugated synthetic peptide derived from human NF-E2 |
Immunogen Range | 273-373/373 |
Clonality | Polyclonal |
Isotype | IgG |
Concentration | 1ug/ul |
Purification | Purified by Protein A. |
Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
Target | |
Gene ID | 4778 |
Swiss Prot | Q16621 |
Subcellular location | Nucleus |
Synonyms | erythroid-derived 2 45 kDa subunit , Leucine zipper protein NF-E2 , Leucine zipper protein NFE2 , NF E2 , nfe2 , NFE2_HUMAN , Nuclear factor (erythroid derived 2), 45kDa , nuclear factor (erythroid-derived 2), 45kD , Nuclear factor , nuclear factor, erythroid 2 , Nuclear factor, erythroid derived 2 45 kDa subunit , p45 , p45 NF-E2 , p45 NFE2 , Transcription factor NF-E2 45 kDa subunit , Transcription factor NFE2 45 kDa subunit . |
Background | NFE2 (Nuclear Factor, Erythroid 2) is a Protein Coding gene. Diseases associated with NFE2 include Essential Thrombocythemia and Spherocytosis, Type 4. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Hematopoietic Stem Cell Differentiation. Gene Ontology (GO) annotations related to this gene include DNA binding transcription factor activity and transcription coactivator activity. An important paralog of this gene is NFE2L1 |
Application Dilution | |
WB | 1:300-5000 |